Get started
Live feed
·
INSIDERFilingvia Quantisnow
Turn Therapeutics Inc. logo

Director Dewhurst Martin William was granted 21,882 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight
Quantisnow market dataNASDAQ
Turn Therapeutics Inc. logo
TTRX
Turn Therapeutics Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Get push alerts for TTRX

Follow TTRX and get a push notification the moment its next story breaks.

Full TTRX profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TTRX (Turn Therapeutics Inc.) and more on Quantisnow.